Global DTaP and Tdap Vaccines Market Growth 2020-2025
According to this study, over the next five years the DTaP and Tdap Vaccines market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in DTaP and Tdap Vaccines business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of DTaP and Tdap Vaccines market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the DTaP and Tdap Vaccines, covering the supply chain analysis, impact assessment to the DTaP and Tdap Vaccines market size growth rate in several scenarios, and the measures to be undertaken by DTaP and Tdap Vaccines companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
DTaP
Td
Tdap
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Adult
Pediatric
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sanofi Pasteur
Lanzhou Institute of Biological Products Co., Ltd
GlaxoSmithKline
Novartis AG
Seqirus
Protein Sciences Corporation
Pfizer Inc
Merck Sharp & Dohme Corp
Johnson & Johnson
Astellas Pharma US, Inc
AstraZeneca
Emergent BioSolutions Inc
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global DTaP and Tdap Vaccines consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of DTaP and Tdap Vaccines market by identifying its various subsegments.
Focuses on the key global DTaP and Tdap Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the DTaP and Tdap Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of DTaP and Tdap Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global DTaP and Tdap Vaccines Consumption 2015-2025
2.1.2 DTaP and Tdap Vaccines Consumption CAGR by Region
2.2 DTaP and Tdap Vaccines Segment by Type
2.2.1 DTaP
2.2.2 Td
2.2.3 Tdap
2.3 DTaP and Tdap Vaccines Consumption by Type
2.3.1 Global DTaP and Tdap Vaccines Consumption Market Share by Type (2015-2020)
2.3.2 Global DTaP and Tdap Vaccines Revenue and Market Share by Type (2015-2020)
2.3.3 Global DTaP and Tdap Vaccines Sale Price by Type (2015-2020)
2.4 DTaP and Tdap Vaccines Segment by Application
2.4.1 Adult
2.4.2 Pediatric
2.5 DTaP and Tdap Vaccines Consumption by Application
2.5.1 Global DTaP and Tdap Vaccines Consumption Market Share by Type (2015-2020)
2.5.2 Global DTaP and Tdap Vaccines Value and Market Share by Type (2015-2020)
2.5.3 Global DTaP and Tdap Vaccines Sale Price by Type (2015-2020)
3 Global DTaP and Tdap Vaccines by Company
3.1 Global DTaP and Tdap Vaccines Sales Market Share by Company
3.1.1 Global DTaP and Tdap Vaccines Sales by Company (2018-2020)
3.1.2 Global DTaP and Tdap Vaccines Sales Market Share by Company (2018-2020)
3.2 Global DTaP and Tdap Vaccines Revenue Market Share by Company
3.2.1 Global DTaP and Tdap Vaccines Revenue by Company (2018-2020)
3.2.2 Global DTaP and Tdap Vaccines Revenue Market Share by Company (2018-2020)
3.3 Global DTaP and Tdap Vaccines Sale Price by Company
3.4 Global DTaP and Tdap Vaccines Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global DTaP and Tdap Vaccines Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players DTaP and Tdap Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 DTaP and Tdap Vaccines by Regions
4.1 DTaP and Tdap Vaccines by Regions
4.2 Americas DTaP and Tdap Vaccines Consumption Growth
4.3 APAC DTaP and Tdap Vaccines Consumption Growth
4.4 Europe DTaP and Tdap Vaccines Consumption Growth
4.5 Middle East & Africa DTaP and Tdap Vaccines Consumption Growth
5 Americas
5.1 Americas DTaP and Tdap Vaccines Consumption by Countries
5.1.1 Americas DTaP and Tdap Vaccines Consumption by Countries (2015-2020)
5.1.2 Americas DTaP and Tdap Vaccines Value by Countries (2015-2020)
5.2 Americas DTaP and Tdap Vaccines Consumption by Type
5.3 Americas DTaP and Tdap Vaccines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC DTaP and Tdap Vaccines Consumption by Regions
6.1.1 APAC DTaP and Tdap Vaccines Consumption by Regions (2015-2020)
6.1.2 APAC DTaP and Tdap Vaccines Value by Regions (2015-2020)
6.2 APAC DTaP and Tdap Vaccines Consumption by Type
6.3 APAC DTaP and Tdap Vaccines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe DTaP and Tdap Vaccines by Countries
7.1.1 Europe DTaP and Tdap Vaccines Consumption by Countries (2015-2020)
7.1.2 Europe DTaP and Tdap Vaccines Value by Countries (2015-2020)
7.2 Europe DTaP and Tdap Vaccines Consumption by Type
7.3 Europe DTaP and Tdap Vaccines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa DTaP and Tdap Vaccines by Countries
8.1.1 Middle East & Africa DTaP and Tdap Vaccines Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa DTaP and Tdap Vaccines Value by Countries (2015-2020)
8.2 Middle East & Africa DTaP and Tdap Vaccines Consumption by Type
8.3 Middle East & Africa DTaP and Tdap Vaccines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 DTaP and Tdap Vaccines Distributors
10.3 DTaP and Tdap Vaccines Customer
11 Global DTaP and Tdap Vaccines Market Forecast
11.1 Global DTaP and Tdap Vaccines Consumption Forecast (2021-2025)
11.2 Global DTaP and Tdap Vaccines Forecast by Regions
11.2.1 Global DTaP and Tdap Vaccines Forecast by Regions (2021-2025)
11.2.2 Global DTaP and Tdap Vaccines Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global DTaP and Tdap Vaccines Forecast by Type
11.8 Global DTaP and Tdap Vaccines Forecast by Application
12 Key Players Analysis
12.1 Sanofi Pasteur
12.1.1 Company Information
12.1.2 DTaP and Tdap Vaccines Product Offered
12.1.3 Sanofi Pasteur DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Sanofi Pasteur Latest Developments
12.2 Lanzhou Institute of Biological Products Co., Ltd
12.2.1 Company Information
12.2.2 DTaP and Tdap Vaccines Product Offered
12.2.3 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Lanzhou Institute of Biological Products Co., Ltd Latest Developments
12.3 GlaxoSmithKline
12.3.1 Company Information
12.3.2 DTaP and Tdap Vaccines Product Offered
12.3.3 GlaxoSmithKline DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 GlaxoSmithKline Latest Developments
12.4 Novartis AG
12.4.1 Company Information
12.4.2 DTaP and Tdap Vaccines Product Offered
12.4.3 Novartis AG DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Novartis AG Latest Developments
12.5 Seqirus
12.5.1 Company Information
12.5.2 DTaP and Tdap Vaccines Product Offered
12.5.3 Seqirus DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Seqirus Latest Developments
12.6 Protein Sciences Corporation
12.6.1 Company Information
12.6.2 DTaP and Tdap Vaccines Product Offered
12.6.3 Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Protein Sciences Corporation Latest Developments
12.7 Pfizer Inc
12.7.1 Company Information
12.7.2 DTaP and Tdap Vaccines Product Offered
12.7.3 Pfizer Inc DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Pfizer Inc Latest Developments
12.8 Merck Sharp & Dohme Corp
12.8.1 Company Information
12.8.2 DTaP and Tdap Vaccines Product Offered
12.8.3 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Merck Sharp & Dohme Corp Latest Developments
12.9 Johnson & Johnson
12.9.1 Company Information
12.9.2 DTaP and Tdap Vaccines Product Offered
12.9.3 Johnson & Johnson DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Johnson & Johnson Latest Developments
12.10 Astellas Pharma US, Inc
12.10.1 Company Information
12.10.2 DTaP and Tdap Vaccines Product Offered
12.10.3 Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Astellas Pharma US, Inc Latest Developments
12.11 AstraZeneca
12.11.1 Company Information
12.11.2 DTaP and Tdap Vaccines Product Offered
12.11.3 AstraZeneca DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 AstraZeneca Latest Developments
12.12 Emergent BioSolutions Inc
12.12.1 Company Information
12.12.2 DTaP and Tdap Vaccines Product Offered
12.12.3 Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Emergent BioSolutions Inc Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. DTaP and Tdap Vaccines Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of DTaP
Table 5. Major Players of Td
Table 6. Major Players of Tdap
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global DTaP and Tdap Vaccines Consumption Market Share by Type (2015-2020)
Table 9. Global DTaP and Tdap Vaccines Revenue by Type (2015-2020) ($ million)
Table 10. Global DTaP and Tdap Vaccines Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global DTaP and Tdap Vaccines Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global DTaP and Tdap Vaccines Consumption Market Share by Application (2015-2020)
Table 14. Global DTaP and Tdap Vaccines Value by Application (2015-2020)
Table 15. Global DTaP and Tdap Vaccines Value Market Share by Application (2015-2020)
Table 16. Global DTaP and Tdap Vaccines Sale Price by Application (2015-2020)
Table 17. Global DTaP and Tdap Vaccines Sales by Company (2017-2019) (K Units)
Table 18. Global DTaP and Tdap Vaccines Sales Market Share by Company (2017-2019)
Table 19. Global DTaP and Tdap Vaccines Revenue by Company (2017-2019) ($ Millions)
Table 20. Global DTaP and Tdap Vaccines Revenue Market Share by Company (2017-2019)
Table 21. Global DTaP and Tdap Vaccines Sale Price by Company (2017-2019)
Table 22. Global DTaP and Tdap Vaccines Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players DTaP and Tdap Vaccines Products Offered
Table 24. DTaP and Tdap Vaccines Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global DTaP and Tdap Vaccines Consumption by Regions 2015-2020 (K Units)
Table 26. Global DTaP and Tdap Vaccines Consumption Market Share by Regions 2015-2020
Table 27. Global DTaP and Tdap Vaccines Value by Regions 2015-2020 ($ Millions)
Table 28. Global DTaP and Tdap Vaccines Value Market Share by Regions 2015-2020
Table 29. Americas DTaP and Tdap Vaccines Consumption by Countries (2015-2020) (K Units)
Table 30. Americas DTaP and Tdap Vaccines Consumption Market Share by Countries (2015-2020)
Table 31. Americas DTaP and Tdap Vaccines Value by Countries (2015-2020) ($ Millions)
Table 32. Americas DTaP and Tdap Vaccines Value Market Share by Countries (2015-2020)
Table 33. Americas DTaP and Tdap Vaccines Consumption by Type (2015-2020) (K Units)
Table 34. Americas DTaP and Tdap Vaccines Consumption Market Share by Type (2015-2020)
Table 35. Americas DTaP and Tdap Vaccines Consumption by Application (2015-2020) (K Units)
Table 36. Americas DTaP and Tdap Vaccines Consumption Market Share by Application (2015-2020)
Table 37. APAC DTaP and Tdap Vaccines Consumption by Regions (2015-2020) (K Units)
Table 38. APAC DTaP and Tdap Vaccines Consumption Market Share by Regions (2015-2020)
Table 39. APAC DTaP and Tdap Vaccines Value by Regions (2015-2020) ($ Millions)
Table 40. APAC DTaP and Tdap Vaccines Value Market Share by Regions (2015-2020)
Table 41. APAC DTaP and Tdap Vaccines Consumption by Type (2015-2020) (K Units)
Table 42. APAC DTaP and Tdap Vaccines Consumption Market Share by Type (2015-2020)
Table 43. APAC DTaP and Tdap Vaccines Consumption by Application (2015-2020) (K Units)
Table 44. APAC DTaP and Tdap Vaccines Consumption Market Share by Application (2015-2020)
Table 45. Europe DTaP and Tdap Vaccines Consumption by Countries (2015-2020) (K Units)
Table 46. Europe DTaP and Tdap Vaccines Consumption Market Share by Countries (2015-2020)
Table 47. Europe DTaP and Tdap Vaccines Value by Countries (2015-2020) ($ Millions)
Table 48. Europe DTaP and Tdap Vaccines Value Market Share by Countries (2015-2020)
Table 49. Europe DTaP and Tdap Vaccines Consumption by Type (2015-2020) (K Units)
Table 50. Europe DTaP and Tdap Vaccines Consumption Market Share by Type (2015-2020)
Table 51. Europe DTaP and Tdap Vaccines Consumption by Application (2015-2020) (K Units)
Table 52. Europe DTaP and Tdap Vaccines Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa DTaP and Tdap Vaccines Consumption by Countries (2015-2020) (K Units)
Table 54. Middle East & Africa DTaP and Tdap Vaccines Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa DTaP and Tdap Vaccines Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa DTaP and Tdap Vaccines Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa DTaP and Tdap Vaccines Consumption by Type (2015-2020) (K Units)
Table 58. Middle East & Africa DTaP and Tdap Vaccines Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa DTaP and Tdap Vaccines Consumption by Application (2015-2020) (K Units)
Table 60. Middle East & Africa DTaP and Tdap Vaccines Consumption Market Share by Application (2015-2020)
Table 61. DTaP and Tdap Vaccines Distributors List
Table 62. DTaP and Tdap Vaccines Customer List
Table 63. Global DTaP and Tdap Vaccines Consumption Forecast by Countries (2021-2025) (K Units)
Table 64. Global DTaP and Tdap Vaccines Consumption Market Forecast by Regions
Table 65. Global DTaP and Tdap Vaccines Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global DTaP and Tdap Vaccines Value Market Share Forecast by Regions
Table 67. Global DTaP and Tdap Vaccines Consumption Forecast by Type (2021-2025) (K Units)
Table 68. Global DTaP and Tdap Vaccines Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global DTaP and Tdap Vaccines Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global DTaP and Tdap Vaccines Value Market Share Forecast by Type (2021-2025)
Table 71. Global DTaP and Tdap Vaccines Consumption Forecast by Application (2021-2025) (K Units)
Table 72. Global DTaP and Tdap Vaccines Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global DTaP and Tdap Vaccines Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global DTaP and Tdap Vaccines Value Market Share Forecast by Application (2021-2025)
Table 75. Sanofi Pasteur Product Offered
Table 76. Sanofi Pasteur DTaP and Tdap Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 77. Sanofi Pasteur Main Business
Table 78. Sanofi Pasteur Latest Developments
Table 79. Sanofi Pasteur Basic Information, Company Total Revenue (in $ million), DTaP and Tdap Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 80. Lanzhou Institute of Biological Products Co., Ltd Product Offered
Table 81. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 82. Lanzhou Institute of Biological Products Co., Ltd Main Business
Table 83. Lanzhou Institute of Biological Products Co., Ltd Latest Developments
Table 84. Lanzhou Institute of Biological Products Co., Ltd Basic Information, Company Total Revenue (in $ million), DTaP and Tdap Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 85. GlaxoSmithKline Product Offered
Table 86. GlaxoSmithKline DTaP and Tdap Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 87. GlaxoSmithKline Main Business
Table 88. GlaxoSmithKline Latest Developments
Table 89. GlaxoSmithKline Basic Information, Company Total Revenue (in $ million), DTaP and Tdap Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 90. Novartis AG Product Offered
Table 91. Novartis AG DTaP and Tdap Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 92. Novartis AG Main Business
Table 93. Novartis AG Latest Developments
Table 94. Novartis AG Basic Information, Company Total Revenue (in $ million), DTaP and Tdap Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 95. Seqirus Product Offered
Table 96. Seqirus DTaP and Tdap Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 97. Seqirus Main Business
Table 98. Seqirus Latest Developments
Table 99. Seqirus Basic Information, Company Total Revenue (in $ million), DTaP and Tdap Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 100. Protein Sciences Corporation Product Offered
Table 101. Protein Sciences Corporation DTaP and Tdap Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 102. Protein Sciences Corporation Main Business
Table 103. Protein Sciences Corporation Latest Developments
Table 104. Protein Sciences Corporation Basic Information, Company Total Revenue (in $ million), DTaP and Tdap Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 105. Pfizer Inc Product Offered
Table 106. Pfizer Inc Basic Information, Company Total Revenue (in $ million), DTaP and Tdap Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 107. Pfizer Inc Main Business
Table 108. Pfizer Inc Latest Developments
Table 109. Pfizer Inc DTaP and Tdap Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 110. Merck Sharp & Dohme Corp Product Offered
Table 111. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 112. Merck Sharp & Dohme Corp Main Business
Table 113. Merck Sharp & Dohme Corp Latest Developments
Table 114. Merck Sharp & Dohme Corp Basic Information, Company Total Revenue (in $ million), DTaP and Tdap Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 115. Johnson & Johnson Product Offered
Table 116. Johnson & Johnson DTaP and Tdap Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 117. Johnson & Johnson Main Business
Table 118. Johnson & Johnson Latest Developments
Table 119. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), DTaP and Tdap Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 120. Astellas Pharma US, Inc Product Offered
Table 121. Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 122. Astellas Pharma US, Inc Main Business
Table 123. Astellas Pharma US, Inc Latest Developments
Table 124. Astellas Pharma US, Inc Basic Information, Company Total Revenue (in $ million), DTaP and Tdap Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 125. AstraZeneca Product Offered
Table 126. AstraZeneca DTaP and Tdap Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 127. AstraZeneca Main Business
Table 128. AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. AstraZeneca Latest Developments
Table 130. Emergent BioSolutions Inc Product Offered
Table 131. Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 132. Emergent BioSolutions Inc Main Business
Table 133. Emergent BioSolutions Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 134. Emergent BioSolutions Inc Latest Developments
List of Figures
Figure 1. Picture of DTaP and Tdap Vaccines
Figure 2. DTaP and Tdap Vaccines Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global DTaP and Tdap Vaccines Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global DTaP and Tdap Vaccines Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of DTaP
Figure 7. Product Picture of Td
Figure 8. Product Picture of Tdap
Figure 9. Global DTaP and Tdap Vaccines Consumption Market Share by Type (2015-2020)
Figure 10. Global DTaP and Tdap Vaccines Value Market Share by Type (2015-2020)
Figure 11. DTaP and Tdap Vaccines Consumed in Adult
Figure 12. Global DTaP and Tdap Vaccines Market: Adult (2015-2020) (K Units)
Figure 13. Global DTaP and Tdap Vaccines Market: Adult (2015-2020) ($ Millions)
Figure 14. DTaP and Tdap Vaccines Consumed in Pediatric
Figure 15. Global DTaP and Tdap Vaccines Market: Pediatric (2015-2020) (K Units)
Figure 16. Global DTaP and Tdap Vaccines Market: Pediatric (2015-2020) ($ Millions)
Figure 17. Global DTaP and Tdap Vaccines Consumption Market Share by Application (2015-2020)
Figure 18. Global DTaP and Tdap Vaccines Value Market Share by Application (2015-2020)
Figure 19. Global DTaP and Tdap Vaccines Sales Market Share by Company in 2017
Figure 20. Global DTaP and Tdap Vaccines Sales Market Share by Company in 2019
Figure 21. Global DTaP and Tdap Vaccines Revenue Market Share by Company in 2017
Figure 22. Global DTaP and Tdap Vaccines Revenue Market Share by Company in 2019
Figure 23. Global DTaP and Tdap Vaccines Sale Price by Company in 2019
Figure 24. Global DTaP and Tdap Vaccines Consumption Market Share by Regions 2015-2020
Figure 25. Global DTaP and Tdap Vaccines Value Market Share by Regions 2015-2020
Figure 26. Americas DTaP and Tdap Vaccines Consumption 2015-2020 (K Units)
Figure 27. Americas DTaP and Tdap Vaccines Value 2015-2020 ($ Millions)
Figure 28. APAC DTaP and Tdap Vaccines Consumption 2015-2020 (K Units)
Figure 29. APAC DTaP and Tdap Vaccines Value 2015-2020 ($ Millions)
Figure 30. Europe DTaP and Tdap Vaccines Consumption 2015-2020 (K Units)
Figure 31. Europe DTaP and Tdap Vaccines Value 2015-2020 ($ Millions)
Figure 32. Middle East & Africa DTaP and Tdap Vaccines Consumption 2015-2020 (K Units)
Figure 33. Middle East & Africa DTaP and Tdap Vaccines Value 2015-2020 ($ Millions)
Figure 34. Americas DTaP and Tdap Vaccines Consumption Market Share by Countries in 2019
Figure 35. Americas DTaP and Tdap Vaccines Value Market Share by Countries in 2019
Figure 36. Americas DTaP and Tdap Vaccines Consumption Market Share by Type in 2019
Figure 37. Americas DTaP and Tdap Vaccines Consumption Market Share by Application in 2019
Figure 38. United States DTaP and Tdap Vaccines Consumption Growth 2015-2020 (K Units)
Figure 39. United States DTaP and Tdap Vaccines Value Growth 2015-2020 ($ Millions)
Figure 40. Canada DTaP and Tdap Vaccines Consumption Growth 2015-2020 (K Units)
Figure 41. Canada DTaP and Tdap Vaccines Value Growth 2015-2020 ($ Millions)
Figure 42. Mexico DTaP and Tdap Vaccines Consumption Growth 2015-2020 (K Units)
Figure 43. Mexico DTaP and Tdap Vaccines Value Growth 2015-2020 ($ Millions)
Figure 44. APAC DTaP and Tdap Vaccines Consumption Market Share by Countries in 2019
Figure 45. APAC DTaP and Tdap Vaccines Value Market Share by Regions in 2019
Figure 46. APAC DTaP and Tdap Vaccines Consumption Market Share by Type in 2019
Figure 47. APAC DTaP and Tdap Vaccines Consumption Market Share by Application in 2019
Figure 48. China DTaP and Tdap Vaccines Consumption Growth 2015-2020 (K Units)
Figure 49. China DTaP and Tdap Vaccines Value Growth 2015-2020 ($ Millions)
Figure 50. Japan DTaP and Tdap Vaccines Consumption Growth 2015-2020 (K Units)
Figure 51. Japan DTaP and Tdap Vaccines Value Growth 2015-2020 ($ Millions)
Figure 52. Korea DTaP and Tdap Vaccines Consumption Growth 2015-2020 (K Units)
Figure 53. Korea DTaP and Tdap Vaccines Value Growth 2015-2020 ($ Millions)
Figure 54. Southeast Asia DTaP and Tdap Vaccines Consumption Growth 2015-2020 (K Units)
Figure 55. Southeast Asia DTaP and Tdap Vaccines Value Growth 2015-2020 ($ Millions)
Figure 56. India DTaP and Tdap Vaccines Consumption Growth 2015-2020 (K Units)
Figure 57. India DTaP and Tdap Vaccines Value Growth 2015-2020 ($ Millions)
Figure 58. Australia DTaP and Tdap Vaccines Consumption Growth 2015-2020 (K Units)
Figure 59. Australia DTaP and Tdap Vaccines Value Growth 2015-2020 ($ Millions)
Figure 60. Europe DTaP and Tdap Vaccines Consumption Market Share by Countries in 2019
Figure 61. Europe DTaP and Tdap Vaccines Value Market Share by Countries in 2019
Figure 62. Europe DTaP and Tdap Vaccines Consumption Market Share by Type in 2019
Figure 63. Europe DTaP and Tdap Vaccines Consumption Market Share by Application in 2019
Figure 64. Germany DTaP and Tdap Vaccines Consumption Growth 2015-2020 (K Units)
Figure 65. Germany DTaP and Tdap Vaccines Value Growth 2015-2020 ($ Millions)
Figure 66. France DTaP and Tdap Vaccines Consumption Growth 2015-2020 (K Units)
Figure 67. France DTaP and Tdap Vaccines Value Growth 2015-2020 ($ Millions)
Figure 68. UK DTaP and Tdap Vaccines Consumption Growth 2015-2020 (K Units)
Figure 69. UK DTaP and Tdap Vaccines Value Growth 2015-2020 ($ Millions)
Figure 70. Italy DTaP and Tdap Vaccines Consumption Growth 2015-2020 (K Units)
Figure 71. Italy DTaP and Tdap Vaccines Value Growth 2015-2020 ($ Millions)
Figure 72. Russia DTaP and Tdap Vaccines Consumption Growth 2015-2020 (K Units)
Figure 73. Russia DTaP and Tdap Vaccines Value Growth 2015-2020 ($ Millions)
Figure 74. Middle East & Africa DTaP and Tdap Vaccines Consumption Market Share by Countries in 2019
Figure 75. Middle East & Africa DTaP and Tdap Vaccines Value Market Share by Countries in 2019
Figure 76. Middle East & Africa DTaP and Tdap Vaccines Consumption Market Share by Type in 2019
Figure 77. Middle East & Africa DTaP and Tdap Vaccines Consumption Market Share by Application in 2019
Figure 78. Egypt DTaP and Tdap Vaccines Consumption Growth 2015-2020 (K Units)
Figure 79. Egypt DTaP and Tdap Vaccines Value Growth 2015-2020 ($ Millions)
Figure 80. South Africa DTaP and Tdap Vaccines Consumption Growth 2015-2020 (K Units)
Figure 81. South Africa DTaP and Tdap Vaccines Value Growth 2015-2020 ($ Millions)
Figure 82. Israel DTaP and Tdap Vaccines Consumption Growth 2015-2020 (K Units)
Figure 83. Israel DTaP and Tdap Vaccines Value Growth 2015-2020 ($ Millions)
Figure 84. Turkey DTaP and Tdap Vaccines Consumption Growth 2015-2020 (K Units)
Figure 85. Turkey DTaP and Tdap Vaccines Value Growth 2015-2020 ($ Millions)
Figure 86. GCC Countries DTaP and Tdap Vaccines Consumption Growth 2015-2020 (K Units)
Figure 87. GCC Countries DTaP and Tdap Vaccines Value Growth 2015-2020 ($ Millions)
Figure 88. Global DTaP and Tdap Vaccines Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 89. Global DTaP and Tdap Vaccines Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 90. Americas DTaP and Tdap Vaccines Consumption 2021-2025 (K Units)
Figure 91. Americas DTaP and Tdap Vaccines Value 2021-2025 ($ Millions)
Figure 92. APAC DTaP and Tdap Vaccines Consumption 2021-2025 (K Units)
Figure 93. APAC DTaP and Tdap Vaccines Value 2021-2025 ($ Millions)
Figure 94. Europe DTaP and Tdap Vaccines Consumption 2021-2025 (K Units)
Figure 95. Europe DTaP and Tdap Vaccines Value 2021-2025 ($ Millions)
Figure 96. Middle East & Africa DTaP and Tdap Vaccines Consumption 2021-2025 (K Units)
Figure 97. Middle East & Africa DTaP and Tdap Vaccines Value 2021-2025 ($ Millions)
Figure 98. United States DTaP and Tdap Vaccines Consumption 2021-2025 (K Units)
Figure 99. United States DTaP and Tdap Vaccines Value 2021-2025 ($ Millions)
Figure 100. Canada DTaP and Tdap Vaccines Consumption 2021-2025 (K Units)
Figure 101. Canada DTaP and Tdap Vaccines Value 2021-2025 ($ Millions)
Figure 102. Mexico DTaP and Tdap Vaccines Consumption 2021-2025 (K Units)
Figure 103. Mexico DTaP and Tdap Vaccines Value 2021-2025 ($ Millions)
Figure 104. Brazil DTaP and Tdap Vaccines Consumption 2021-2025 (K Units)
Figure 105. Brazil DTaP and Tdap Vaccines Value 2021-2025 ($ Millions)
Figure 106. China DTaP and Tdap Vaccines Consumption 2021-2025 (K Units)
Figure 107. China DTaP and Tdap Vaccines Value 2021-2025 ($ Millions)
Figure 108. Japan DTaP and Tdap Vaccines Consumption 2021-2025 (K Units)
Figure 109. Japan DTaP and Tdap Vaccines Value 2021-2025 ($ Millions)
Figure 110. Korea DTaP and Tdap Vaccines Consumption 2021-2025 (K Units)
Figure 111. Korea DTaP and Tdap Vaccines Value 2021-2025 ($ Millions)
Figure 112. Southeast Asia DTaP and Tdap Vaccines Consumption 2021-2025 (K Units)
Figure 113. Southeast Asia DTaP and Tdap Vaccines Value 2021-2025 ($ Millions)
Figure 114. India DTaP and Tdap Vaccines Consumption 2021-2025 (K Units)
Figure 115. India DTaP and Tdap Vaccines Value 2021-2025 ($ Millions)
Figure 116. Australia DTaP and Tdap Vaccines Consumption 2021-2025 (K Units)
Figure 117. Australia DTaP and Tdap Vaccines Value 2021-2025 ($ Millions)
Figure 118. Germany DTaP and Tdap Vaccines Consumption 2021-2025 (K Units)
Figure 119. Germany DTaP and Tdap Vaccines Value 2021-2025 ($ Millions)
Figure 120. France DTaP and Tdap Vaccines Consumption 2021-2025 (K Units)
Figure 121. France DTaP and Tdap Vaccines Value 2021-2025 ($ Millions)
Figure 122. UK DTaP and Tdap Vaccines Consumption 2021-2025 (K Units)
Figure 123. UK DTaP and Tdap Vaccines Value 2021-2025 ($ Millions)
Figure 124. Italy DTaP and Tdap Vaccines Consumption 2021-2025 (K Units)
Figure 125. Italy DTaP and Tdap Vaccines Value 2021-2025 ($ Millions)
Figure 126. Russia DTaP and Tdap Vaccines Consumption 2021-2025 (K Units)
Figure 127. Russia DTaP and Tdap Vaccines Value 2021-2025 ($ Millions)
Figure 128. Spain DTaP and Tdap Vaccines Consumption 2021-2025 (K Units)
Figure 129. Spain DTaP and Tdap Vaccines Value 2021-2025 ($ Millions)
Figure 130. Egypt DTaP and Tdap Vaccines Consumption 2021-2025 (K Units)
Figure 131. Egypt DTaP and Tdap Vaccines Value 2021-2025 ($ Millions)
Figure 132. South Africa DTaP and Tdap Vaccines Consumption 2021-2025 (K Units)
Figure 133. South Africa DTaP and Tdap Vaccines Value 2021-2025 ($ Millions)
Figure 134. Israel DTaP and Tdap Vaccines Consumption 2021-2025 (K Units)
Figure 135. Israel DTaP and Tdap Vaccines Value 2021-2025 ($ Millions)
Figure 136. Turkey DTaP and Tdap Vaccines Consumption 2021-2025 (K Units)
Figure 137. Turkey DTaP and Tdap Vaccines Value 2021-2025 ($ Millions)
Figure 138. GCC Countries DTaP and Tdap Vaccines Consumption 2021-2025 (K Units)
Figure 139. GCC Countries DTaP and Tdap Vaccines Value 2021-2025 ($ Millions)
Figure 140. Sanofi Pasteur DTaP and Tdap Vaccines Market Share (2018-2020)
Figure 141. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Market Share (2018-2020)
Figure 142. GlaxoSmithKline DTaP and Tdap Vaccines Market Share (2018-2020)
Figure 143. Novartis AG DTaP and Tdap Vaccines Market Share (2018-2020)
Figure 144. Seqirus DTaP and Tdap Vaccines Market Share (2018-2020)
Figure 145. Protein Sciences Corporation DTaP and Tdap Vaccines Market Share (2018-2020)
Figure 146. Pfizer Inc DTaP and Tdap Vaccines Market Share (2018-2020)
Figure 147. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Market Share (2018-2020)
Figure 148. Johnson & Johnson DTaP and Tdap Vaccines Market Share (2018-2020)
Figure 149. Astellas Pharma US, Inc DTaP and Tdap Vaccines Market Share (2018-2020)
Figure 150. AstraZeneca DTaP and Tdap Vaccines Market Share (2018-2020)
Figure 151. Emergent BioSolutions Inc DTaP and Tdap Vaccines Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets